Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study

Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study

The effect of interferon (IFN) beta-1a (44 and 22 μg subcutaneously [sc] three times weekly [tiw]) on cognition in mildly disabled patients with relapsing—remitting multiple sclerosis (McDonald criteria; Expanded Disability Status Scale ≤4.0) was assessed by validated neuropsychological testing at b...

Full description

Bibliographic Details
Main Authors: Francesco Patti, Maria Pia Amato, Stefano Bastianello, Luisa Caniatti, Elisabetta Di Monte, Fausto Lijoi, Benedetta Goretti, Silvia Messina, Orietta Picconi, Maria Rosalia Tola, Maria Trojano
Format: Article
Language:English
Published: SAGE Publishing 2009-03-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756285608101379

Similar Items

Similar Items